Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Kymera Therapeutics Inc
(NQ:
KYMR
)
45.89
+0.87 (+1.93%)
Streaming Delayed Price
Updated: 10:33 AM EDT, Oct 14, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Kymera Therapeutics Inc
< Previous
1
2
3
4
Next >
The Analyst Landscape: 7 Takes On Kymera Therapeutics
September 27, 2024
Via
Benzinga
Cracking The Code: Understanding Analyst Reviews For Kymera Therapeutics
September 09, 2024
Via
Benzinga
This BJ's Wholesale Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Monday
August 26, 2024
Via
Benzinga
Unveiling 6 Analyst Insights On Kymera Therapeutics
August 12, 2024
Via
Benzinga
XPeng & QuantumScape Are Among Top 11 Mid Cap Stocks That Performed Well Last Week (July 7-July 13): Details
July 14, 2024
10 mid-cap stocks jumped in last week, including QuantumScape, Lantheus Holdings, Sunrun, Kymera Therapeutics, Apogee Therapeutics, Joby Aviation, Crinetics Pharmaceuticals, Dyne Therapeutics, Summit...
Via
Benzinga
Why Kymera Therapeutics Stock Is Soaring Today
July 09, 2024
Kymera's lead pipeline candidate received some good news.
Via
The Motley Fool
Cracking The Code: Understanding Analyst Reviews For Kymera Therapeutics
June 17, 2024
Via
Benzinga
Demystifying Kymera Therapeutics: Insights From 5 Analyst Reviews
May 24, 2024
Via
Benzinga
Kymera Therapeutics Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)
April 22, 2024
Via
Benzinga
Why Helen of Troy Shares Are Trading Lower By Around 30%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
July 09, 2024
Via
Benzinga
Nvidia, Micron, Arlo Technologies And Other Big Stocks Moving Higher On Tuesday
July 09, 2024
Via
Benzinga
KYMR Stock Earnings: Kymera Therapeutics Beats EPS, Misses Revenue for Q1 2024
May 02, 2024
KYMR stock results show that Kymera Therapeutics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via
InvestorPlace
Breaking Down Kymera Therapeutics: 4 Analysts Share Their Views
February 23, 2024
Via
Benzinga
Deep Dive Into Kymera Therapeutics Stock: Analyst Perspectives (4 Ratings)
December 19, 2023
Via
Benzinga
Analyst Expectations for Kymera Therapeutics's Future
November 13, 2023
Via
Benzinga
Piper Sandler Maintains Overweight Rating for Kymera Therapeutics: Here's What You Need To Know
February 27, 2024
Via
Benzinga
Kymera Therapeutics Stock Whiplash: Shares Soar, Then Tumble After $275 Million Offering
January 05, 2024
Shares soared and then tumbled Friday after the company offered $275 million in public shares.
Via
Investor's Business Daily
More Than $10M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying
November 07, 2023
Although U.S. stocks closed slightly higher on Monday, there were a few notable insider trades.
Via
Benzinga
HC Wainwright & Co. Maintains Buy Rating for Kymera Therapeutics: Here's What You Need To Know
November 03, 2023
Via
Benzinga
Why Shares of Kymera Therapeutics Jumped on Tuesday
October 03, 2023
The company had a big bounce after hitting a 52-week low the day before.
Via
The Motley Fool
Verizon To Rally Around 20%? Here Are 10 Other Analyst Forecasts For Tuesday
August 29, 2023
Stifel raised the price target for Hersha Hospitality Trust (NYSE: HT) from $8.75 to $10. Stifel analyst Simon Yarmak downgraded the stock from Buy to Hold. Hersha Hospitality Trust shares fell 0.5% to...
Via
Benzinga
Expert Ratings for Kymera Therapeutics
August 04, 2023
Via
Benzinga
What 5 Analyst Ratings Have To Say About Kymera Therapeutics
June 15, 2023
Via
Benzinga
Earnings Scheduled For February 22, 2024
February 22, 2024
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings at $0.28 per share on revenue of $260.00 million.
Via
Benzinga
Preview: Kymera Therapeutics's Earnings
November 01, 2023
Via
Benzinga
The Latest Analyst Ratings for Kymera Therapeutics
August 29, 2023
Via
Benzinga
Why CalAmp Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Friday's Mid-Day Session
October 06, 2023
Gainers
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 30, 2023
June 30, 2023
Via
Benzinga
Why Guidewire Software Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session
June 02, 2023
Gainers MultiMetaVerse Holdings Limited (NASDAQ: MMV) gained 236% to $3.1592 after the company announced it signed a non-binding term sheet to acquire an equity stake in Taomee group.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
June 02, 2023
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.